We thank Dr. Eva Gluenz from the University of Oxford for providing us with the plasmids for performing CRISPR-Cas9 in Leishmania. We thank Prof. Charles Jaffe (Hebrew University, Israel) for providing us with the L. mexicana strain M379. We thank the Smoler Proteomics Center in the Technion, Haifa, for their proteomic analysis. We are also grateful to Prof. Dina Raveh for editing this manuscript and for helpful discussions.